Hvivo (HVO)

Sector:

Health Care

Index:

FTSE AIM All-Share

 0.000p
   
  • Closing Price Chg:
      0.000p
  • 52 Week High: 21.00p
  • 52 Week Low: 5.00p
  • Currency: UK Pounds
  • Shares Issued: 687.01m
  • Volume: 0
  • Beta: 0.05

Financial Analysis

Select chart: EPS | Dividend | Revenue

Latest Interim/Quarterly

Period Ending Period Revenue (£m) Pre-tax (£m) EPS Dividend
30-Jun-25 Interim 24.19 (0.14) (0.29)p n/a

Key Fundamentals

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 20.60 (10.98) (1.80)p n/a n/a n/a n/a 0.0%
31-Dec-21 36.86 0.28 (0.19)p n/a n/a n/a n/a 0.0%
31-Dec-22 48.48 (0.37) 0.96p 10.4 n/a n/a 0.45p 4.5%
31-Dec-23 56.04 11.15 1.27p 18.7 0.6 +32% 0.20p 0.8%
31-Dec-24 62.72 13.29 1.69p 12.1 0.4 +33% 0.20p 1.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Forecasts

Year Ending Revenue (£m) Pre-tax (£m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-25 47.03 (6.16) (0.71)p n/a n/a n/a 0.20p 0.0%
31-Dec-26 50.89 (3.43) (0.43)p n/a n/a n/a 0.20p 0.0%
31-Dec-27 54.94 (0.96) (0.11)p n/a n/a n/a 0.19p 0.0%

Copyright © 2026 FactSet Research Systems Inc. All rights reserved.

Price / Earnings Data

5 Yr High 5 Yr Low 5 Yr Avg Curr / Avg
Latest 10.42 10.42 n/a 0

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

IFRS Changes - Find Out More

Find out about IFRS and how this affects the financial infomation for all UK companies.

Hvivo Market Data

Currency UK Pounds
Share Price 6.00p
Closing Price Change 0.000p
% Change 0.00 %
52 Week High 21.00p
52 Week Low 5.00p
Volume 0
Shares Issued 687.01m
Beta 0.05

Hvivo Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
0.22% below the market average0.22% below the market average0.22% below the market average0.22% below the market average0.22% below the market average
3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average3.03% above the sector average
Price Trend
83.6% below the market average83.6% below the market average83.6% below the market average83.6% below the market average83.6% below the market average
48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average48.57% below the sector average
Income
10.89% below the market average10.89% below the market average10.89% below the market average10.89% below the market average10.89% below the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Growth
72.90% above the market average72.90% above the market average72.90% above the market average72.90% above the market average72.90% above the market average
8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average8.57% below the sector average

What The Brokers Say

Strong Buy 1
Buy 4
Neutral 2
Sell 0
Strong Sell 0
Total 7
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Hvivo Dividends

  Latest Previous
  Final Final
Ex-Div 15-May-25 18-Apr-24
Paid 11-Jun-25 20-May-24
Amount 0.20p 0.20p

Trades for --2026

Time Volume / Share Price
0 @ 0.000p

Hvivo Key Personnel

CEO Yamin Mo' Khan

Top of Page